Featured Post

Latest Gold News

Fed doves supporting gold Stronger rand crushing South African miners Economic power could shift further East with Hong Kong gold exch...

Tuesday, November 22, 2011

Pharmasset (VRUS) Ratings, Price Targets

Pharmasset (VRUS) ratings and price targets.

Leerink downgraded Pharmasset from an “Outperform” rating to a “Market Perform” rating.

Canaccord Genuity downgraded Pharmasset from a “Buy” rating to a “Hold” rating.

JPMorgan Chase & Co. (NYSE:JPM) downgraded Pharmasset from an “Overweight” rating to a “Neutral” rating. They have a price target of $137.00 on the company.

Wells Fargo & Co. (NYSE:WFC) downgraded Pharmasset from an “Outperform” rating to a “Market Perform” rating.

No comments: